Pages that link to "Q53517374"
Jump to navigation
Jump to search
The following pages link to Effect of levetiracetam on epilepsy-related quality of life. N132 Study Group. (Q53517374):
Displaying 50 items.
- Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review (Q24200332) (← links)
- Levetiracetam in the treatment of epilepsy (Q24656333) (← links)
- Levetiracetam add-on for drug-resistant localization related (partial) epilepsy (Q30661918) (← links)
- Levetiracetam. A review of its adjunctive use in the management of partial onset seizures (Q34086045) (← links)
- Neuropsychological effects of epilepsy and antiepileptic drugs (Q34158893) (← links)
- Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations (Q34186198) (← links)
- Health outcomes in persons with epilepsy (Q34254790) (← links)
- A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. (Q34416450) (← links)
- Levetiracetam: a novel antiepileptic drug (Q34443362) (← links)
- Newer therapies in the drug treatment of epilepsy (Q34509364) (← links)
- Levetiracetam: a different approach to the pharmacotherapy of epilepsy (Q34533863) (← links)
- Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: a comparative review of newer versus older agents. (Q34563059) (← links)
- New antiepileptic drugs: comparative studies of efficacy and cognition (Q34566302) (← links)
- Quality of life in patients with epilepsy and impact of treatments (Q35011077) (← links)
- The impact of epilepsy on subjective health status (Q35204014) (← links)
- Levetiracetam: treatment in epilepsy (Q35575012) (← links)
- The cognitive impact of antiepileptic drugs (Q35588407) (← links)
- Health-related quality of life in senior adults with epilepsy: what we know from randomized clinical trials and suggestions for future research (Q35617844) (← links)
- Self-management education for adults with poorly controlled epilepsy (SMILE (UK)): statistical, economic and qualitative analysis plan for a randomised controlled trial (Q35807135) (← links)
- Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy (Q35939585) (← links)
- Benefit-risk assessment of levetiracetam in the treatment of partial seizures (Q36265931) (← links)
- Epilepsy and suicide: pathogenesis, risk factors, and prevention (Q36842197) (← links)
- Levetiracetam: a review of its use in epilepsy (Q37851959) (← links)
- The adverse effects profile of levetiracetam in epilepsy: a more detailed look (Q38164431) (← links)
- Health-related quality of life in double-blind Phase III studies of brivaracetam as adjunctive therapy of focal seizures: A pooled, post-hoc analysis. (Q38942572) (← links)
- Study of Inter-relationship of Depression, Seizure Frequency and Quality of Life of People with Epilepsy in India (Q41877804) (← links)
- The KEEPER trial: levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study (Q42602739) (← links)
- Levetiracetam, lamotrigine, and phenobarbital in patients with epileptic seizures and Alzheimer's disease (Q43147847) (← links)
- Comparative study of five antiepileptic drugs on a translational cognitive measure in the rat: relationship to antiepileptic property (Q43258480) (← links)
- Levetiracetam: an innovative and cost-effective add-on drug for refractory partial epilepsy (Q43266403) (← links)
- Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: an open-label multicenter study (Q43270753) (← links)
- Levetiracetam in refractory pediatric epilepsy (Q44099483) (← links)
- Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam (Q44404649) (← links)
- Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases (Q44607323) (← links)
- Quality of life improvement with conversion to lamotrigine monotherapy (Q44880530) (← links)
- Improved mood states with lamotrigine in patients with epilepsy (Q45067828) (← links)
- Effects of antiepileptic drugs on working memory as assessed by spatial alternation performance in rats (Q45176490) (← links)
- Levetiracetam for people with mental retardation and refractory epilepsy (Q45176495) (← links)
- Positive and negative psychotropic effects of levetiracetam (Q46516531) (← links)
- Effects of antiepileptic drugs on attention as assessed by a five-choice serial reaction time task in rats (Q46777626) (← links)
- Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures (Q46892518) (← links)
- The impact of levetiracetam on challenging behavior (Q46940911) (← links)
- Impact of seizure frequency reduction on health-related quality of life among clinical trial subjects with refractory partial-onset seizures: A pooled analysis of phase III clinical trials of eslicarbazepine acetate (Q47573177) (← links)
- The biopsychosocial model and quality of life in persons with active epilepsy (Q48063030) (← links)
- Epilepsy and quality of life: socio-demographic and clinical aspects, and psychiatric co-morbidity (Q48212703) (← links)
- Changes in seizure severity and quality of life in patients with refractory partial epilepsy (Q48340099) (← links)
- Quality of life of patients with epilepsy in Malaysia (Q48455021) (← links)
- Quality of life in 1931 adult patients with epilepsy: seizures do not tell the whole story (Q48563599) (← links)
- The Greek version of the Quality of Life in Epilepsy Inventory (QOLIE-31). (Q50773171) (← links)
- Association of demographic, clinical and treatment variables with quality of life of patients with epilepsy in Greece (Q50782255) (← links)